{
    "clinical_study": {
        "@rank": "147896", 
        "arm_group": [
            {
                "arm_group_label": "Apixaban", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "UFH/Warfarin", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate safety of apixaban in Japanese acute DVT/PE\n      subjects when symptomatic DVT/PE subjects are treated with 10 mg BID apixaban for 7 days as\n      initial therapy followed by 5 mg BID apixaban for 23 weeks as long-term therapy (total\n      treatment period is 24 weeks)"
        }, 
        "brief_title": "AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Deep Vein Thrombosis", 
            "Pulmonary Embolism"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Embolism", 
                "Pulmonary Embolism", 
                "Thrombosis", 
                "Venous Thrombosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Acute symptomatic proximal DVT with evidence of proximal thrombosis\n\n          -  Acute symptomatic PE with evidence of thrombosis in segmental or more proximal\n             branches\n\n        Exclusion Criteria:\n\n          -  Active bleeding or high risk for bleeding contraindicating treatment with UFH and a\n             VKA.\n\n          -  Uncontrolled hypertension: systolic blood pressure > 180 mm Hg or diastolic blood\n             pressure > 110 mm Hg\n\n          -  Subjects requiring dual anti-platelet therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780987", 
            "org_study_id": "B0661024", 
            "secondary_id": "CV185160"
        }, 
        "intervention": [
            {
                "arm_group_label": "Apixaban", 
                "description": "10 mg BID for 7 days followed by 5 mg BID for 23 weeks (total 24 weeks)", 
                "intervention_name": "Apixaban", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "UFH/Warfarin", 
                "description": "Dosing adjustment based on APTT = 1.5-2.5 times the control value, and until INR \u2265 1.5 for 5 days or more", 
                "intervention_name": "Unfractionated Heparin (UFH)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "UFH/Warfarin", 
                "description": "Dosing for 24 weeks to target INR range between 1.5-2.5", 
                "intervention_name": "Warfarin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium heparin", 
                "Heparin", 
                "Warfarin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DVT", 
            "PE", 
            "VTE"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B0661024&StudyName=AStudy%20To%20Evaluate%20Safety%20And%20Eficacy%20Of%20Apixaban%20In%20Japanese%20Acute%20Deep%20Vein%20Thrombosis%20%28DVT%29%20And%20Pulmonary%20Embolism%20%28PE%29%20Patie"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Nagakute", 
                        "country": "Japan", 
                        "state": "Aichi"
                    }, 
                    "name": "Aichi Medical University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sakura", 
                        "country": "Japan", 
                        "state": "Chiba"
                    }, 
                    "name": "Toho University Sakura Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kitakyusyu", 
                        "country": "Japan", 
                        "state": "Fukuoka"
                    }, 
                    "name": "Kokura Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hatsukaichi", 
                        "country": "Japan", 
                        "state": "Hiroshima"
                    }, 
                    "name": "Hiroshima General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sapporo", 
                        "country": "Japan", 
                        "state": "Hokkaido"
                    }, 
                    "name": "Teine Keijinkai Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kahoku-gun", 
                        "country": "Japan", 
                        "state": "Ishikawa"
                    }, 
                    "name": "Kanazawa Medical University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }, 
                    "name": "Yokohama Minami Kyousai Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }, 
                    "name": "National Hospital Organization Yokohama Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tsu", 
                        "country": "Japan", 
                        "state": "Mie"
                    }, 
                    "name": "Mie University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okayama City", 
                        "country": "Japan", 
                        "state": "Okayama"
                    }, 
                    "name": "National Hospital Organization Okayama Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osakasayama", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }, 
                    "name": "Kinki University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suita-shi", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }, 
                    "name": "National Cerebral and Cardiovascular Center Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuo-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }, 
                    "name": "St. Luke's International Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Itabashi-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }, 
                    "name": "Nihon University Itabashi Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meguro-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }, 
                    "name": "National Hospital Organization Tokyo Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Musashino", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }, 
                    "name": "Japanese Red Cross Musashino Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }, 
                    "name": "Tokyo Medical University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukushima", 
                        "country": "Japan"
                    }, 
                    "name": "Fukushima Medical University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto", 
                        "country": "Japan"
                    }, 
                    "name": "Kumamoto University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto", 
                        "country": "Japan"
                    }, 
                    "name": "Kumamoto City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto", 
                        "country": "Japan"
                    }, 
                    "name": "Saiseikai Kumamoto Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagasaki", 
                        "country": "Japan"
                    }, 
                    "name": "Nagasaki Municipal Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Active-Control, Multicenter, Randomized, Open-Label, Safety And Efficacy Study Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary Embolism In Japanese", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Japan: Pharmaceuticals and Medical Devices Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Major bleeding and Clinically Relevant Non-major bleeding", 
            "safety_issue": "Yes", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780987"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "symptomatic VTE or VTE-related death", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "thrombtic burden deterioration", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Major bleeeding", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "All bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "collaborator": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}